|
synaptic receptor adaptor activity
|
GO_0030160 |
[The binding activity of a molecule that provides a physical support bridging a synaptic signaling receptor and a downstream signaling molecule.] |
|
low-density lipoprotein particle binding
|
GO_0030169 |
[Binding to a low-density lipoprotein particle, a lipoprotein particle that is rich in cholesterol esters and low in triglycerides, is typically composed of APOB100 and APOE, and has a density of 1.02-1.06 g/ml and a diameter of between 20-25 nm.] |
|
lipoprotein particle binding
|
GO_0071813 |
[Binding to a lipoprotein particle. A lipoprotein particle, also known as a lipoprotein, is a clathrate complex consisting of a lipid enwrapped in a protein host without covalent binding in such a way that the complex has a hydrophilic outer surface consisting of all the protein and the polar ends of any phospholipids.] |
|
positive regulation of blood coagulation
|
GO_0030194 |
[Any process that activates or increases the frequency, rate or extent of blood coagulation.] |
|
positive regulation of coagulation
|
GO_0050820 |
[Any process that activates or increases the frequency, rate or extent of coagulation.] |
|
positive regulation of wound healing
|
GO_0090303 |
[Any process that increases the rate, frequency, or extent of the series of events that restore integrity to a damaged tissue, following an injury.] |
|
positive regulation of hemostasis
|
GO_1900048 |
[Any process that activates or increases the frequency, rate or extent of hemostasis.] |
|
regulation of blood coagulation
|
GO_0030193 |
[Any process that modulates the frequency, rate or extent of blood coagulation.] |
|
negative regulation of blood coagulation
|
GO_0030195 |
[Any process that stops, prevents, or reduces the frequency, rate or extent of blood coagulation.] |
|
negative regulation of hemostasis
|
GO_1900047 |
[Any process that stops, prevents or reduces the frequency, rate or extent of hemostasis.] |
|
negative regulation of coagulation
|
GO_0050819 |
[Any process that stops, prevents, or reduces the frequency, rate or extent of coagulation.] |
|
negative regulation of wound healing
|
GO_0061045 |
[Any process that decreases the rate, frequency, or extent of the series of events that restore integrity to a damaged tissue, following an injury.] |
|
cyanide hydratase activity
|
GO_0030196 |
[Catalysis of the reaction: formamide = H2O + hydrogen cyanide.] |
|
hydro-lyase activity
|
GO_0016836 |
[Catalysis of the cleavage of a carbon-oxygen bond by elimination of water.] |
|
extracellular matrix constituent, lubricant activity
|
GO_0030197 |
[Functions as a lubricant for an extracellular matrix, such as a mucous membrane.] |
|
extracellular matrix organization
|
GO_0030198 |
[A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of an extracellular matrix.] |
|
extracellular structure organization
|
GO_0043062 |
[A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of structures in the space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane, and also covers the host cell environment outside an intracellular parasite.] |
|
external encapsulating structure organization
|
GO_0045229 |
[A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of external structures that lie outside the plasma membrane and surround the entire cell.] |
|
collagen fibril organization
|
GO_0030199 |
[Any process that determines the size and arrangement of collagen fibrils within an extracellular matrix.] |
|
obsolete chaperone inhibitor activity
|
GO_0030190 |
[OBSOLETE. Stops, prevents or reduces the activity of a molecular chaperone.] |